Biktarvy and Bone density decreased - a phase IV clinical study of FDA data
Summary:
Bone density decreased is reported as a side effect among people who take Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Truvada, and have Acquired immunodeficiency syndrome.
The phase IV clinical study analyzes which people have Bone density decreased when taking Biktarvy. It is created by eHealthMe based on reports of 19,474 people who have side effects when taking Biktarvy from the FDA, and is updated regularly.
What is Biktarvy?
Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.
What is Bone density decreased?
Bone density decreased is found to be associated with 1,126 drugs and 945 conditions by eHealthMe. Check the latest studies of Bone density decreased.
19,474 people reported to have side effects when taking Biktarvy.
Among them, 9,241 people (47.45%) have Bone density decreased.
Among these 9,241 people:
How long have people been on Biktarvy when they have Bone density decreased? *
What is the gender of people who have Bone density decreased when taking Biktarvy? *
What is the age of people who have Bone density decreased when taking Biktarvy? *
What are other drugs people take besides Biktarvy? *
What are other side effects people have besides Bone density decreased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Biktarvy and have Bone density decreased?
- Check whether Bone density decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Biktarvy:
- Biktarvy (19,543 reports)
Bone density decreased treatments and more:
- Bone density decreased (57,937 reports)
How severe was Bone density decreased and when was it recovered:
Expand to all the drugs that have ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate:
- Bone density decreased and drugs with ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (9,241 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Biktarvy:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bone density decreased:
- Bone density decreased (1,126 drugs)
Browse all the conditions that are associated with Bone density decreased:
- Bone density decreased (945 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Biktarvy) and Biktarvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cetirizine Hydrochloride cause Dyspnea Exertional? - 4 seconds ago
- Drug interactions of Mupirocin and Jakafi - 21 seconds ago
- Drug interactions of Trimipramine Maleate and Pantoprazole Sodium - 23 seconds ago
- Drug interactions of Hydrea and Heparin - 30 seconds ago
- Could Glucotrol cause Abdominal Pain? - 32 seconds ago
- Drug interactions of Losartan and Progesterone - 32 seconds ago
- Could Pradaxa cause Weight Increased? - 51 seconds ago
- Guaifenesin vs. Omnicef, side effect and effectiveness comparison - a minute ago
- Could Accutane cause Acute Kidney Failure? - a minute ago
- Could Rebif cause Abdominal Pain? - a minute ago